Header Logo

Connection

Drew LaBreck to Melanoma, Experimental

Back to Details
This is a "connection" page, showing publications Drew LaBreck has written about Melanoma, Experimental.
Drew LaBreck
Connection Strength
0.059
Melanoma, Experimental
  1. DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation. Elife. 2024 Jul 08; 12.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.